These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6347273)

  • 1. Insulin receptors on leukemia and lymphoma cells.
    Chen PM; Kwan SH; Hwang TS; Chiang BN; Chou CK
    Blood; 1983 Aug; 62(2):251-5. PubMed ID: 6347273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin receptors in acute and chronic lymphoid leukaemias.
    Thomopoulos P; Marie JP
    Eur J Clin Invest; 1980 Oct; 10(5):387-92. PubMed ID: 6777173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific receptors for phorbol diesters on freshly isolated human myeloid and lymphoid leukemia cells: comparable binding characteristics despite different cellular responses.
    Goodwin BJ; Moore JO; Weinberg JB
    Blood; 1984 Feb; 63(2):298-304. PubMed ID: 6318866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of particular isoenzymes in fresh and cultured leukemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme.
    Drexler HG; Gaedicke G; Minowada J
    Cancer; 1986 May; 57(9):1776-82. PubMed ID: 3485468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phytohemagglutinin and interleukin-2 on malignant and nonmalignant B and T lymphocytes.
    Porwit A; Panayotides P; Wasserman J; Reizenstein P
    Cancer Detect Prev; 1988; 12(1-6):91-6. PubMed ID: 3263204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin binding of acute lymphocytic leukemia cells.
    Esber EC; Buell DN; Leikin SL
    Blood; 1976 Jul; 48(1):33-9. PubMed ID: 1084767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concanavalin A-induced agglutination of human leukemic and lymphoma cells.
    Maca RD
    Cancer Res; 1976 Apr; 36(4):1218-21. PubMed ID: 1063062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression.
    Khaldoyanidi S; Achtnich M; Hehlmann R; Zöller M
    Leuk Res; 1996 Oct; 20(10):839-51. PubMed ID: 8960109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivity pattern of 'myeloid monoclonal antibodies' with emphasis on MCS-2.
    Drexler HG; Sagawa K; Menon M; Minowada J
    Leuk Res; 1986; 10(1):17-23. PubMed ID: 3456072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the phytohemagglutinin-induced proliferating lymphocyte subpopulations in chronic lymphocytic leukemia patients using a clonogenic agar technique and monoclonal antibodies.
    Davis S
    Blood; 1981 Nov; 58(5):1053-5. PubMed ID: 6975137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.
    Uchiyama T; Hori T; Tsudo M; Wano Y; Umadome H; Tamori S; Yodoi J; Maeda M; Sawami H; Uchino H
    J Clin Invest; 1985 Aug; 76(2):446-53. PubMed ID: 2993359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro drug resistance in B cell chronic lymphocytic leukemia: a comparison with acute myelocytic and acute lymphocytic leukemia.
    Aleskog A; Larsson R; Höglund M; Kristensen J; Nygren P; Lindhagen E
    Anticancer Drugs; 2005 Mar; 16(3):277-83. PubMed ID: 15711179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy.
    Schmidt M; Hochhaus A; König-Merediz SA; Brendel C; Proba J; Hoppe GJ; Wittig B; Ehninger G; Hehlmann R; Neubauer A
    J Clin Oncol; 2000 Oct; 18(19):3331-8. PubMed ID: 11013272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
    Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
    Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningeal involvement in leukemias and malignant lymphomas of adults: incidence, course of disease, and treatment for prevention.
    Weizsaecker M; Koelmel HW
    Acta Neurol Scand; 1979 Dec; 60(6):363-70. PubMed ID: 297427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody-defined T-cell phenotypes and phytohemagglutinin reactivity of E-rosette-forming circulating lymphocytes from untreated chronic myelocytic leukemia patients.
    Velardi A; Rambotti P; Cernetti C; Spinozzi F; Gerli R; Martelli MF; Davis S
    Cancer; 1984 Feb; 53(4):913-6. PubMed ID: 6607098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A morphological pattern of 234 cases of leukemias.
    Hassan K; Ikram N; Shah SH
    J Pak Med Assoc; 1994 Jun; 44(6):145-8. PubMed ID: 8089909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.